This Pharma And Healthcare Sector Fund Poured 68.74% Returns on 5 Years SIP: Details Here

If you are someone who wants to invest your money in the stock market but doesn't have enough time and knowledge, investing in mutual funds is the best option for you. As the market is volatile and investing is risky. Health sector mutual funds are a good option to enhance your portfolio. This one pharma and healthcare sector fund from one of the reputable mutual fund houses in India has given good returns. In the article, we have given insights into the fund with portfolio and returns. Check out the Tata India Pharma & Healthcare Fund.

Tata India Pharma & Healthcare Fund - Direct Plan-Growth

This fund was launched on 28 December 2015. It is an open-ended Sectoral-Pharma mutual fund scheme from Tata Mutual Fund. The fund has no lock-in period. The fund's Direct-Growth scheme has Rs 528.26 Crores worth of assets under management (AUM), and NAV as of 16th March 2022 is Rs 18.6801. It is a medium-sized fund in the sectoral fund's category. Its expense ratio is 1.08%, which is less than its category average expense ratio. The minimum investment required in this fund is Rs 5000, while the minimum SIP amount to invest in this scheme is Rs 150. It is a highly risky fund. 

The scheme aims to achieve long-term capital appreciation by investing at least 80% of its net assets in equity/equity-related instruments of firms in the country's pharmaceutical and healthcare industries. Investors who seek to make selected bets for better returns than other Equity funds and have a good understanding of this sector can opt to bet on this fund. The fund doesn't guarantee returns. Investment in this fund is subject to market risk. 

Returns Over The Years

Absolute and Annualised Returns

Tata India Pharma & Healthcare Fund Direct-Growth scheme return performance in last 1 year is 17.95%. Since its launch, it has delivered 10.49% average annual returns.

Investment Period	Absolute Returns	Annualised Returns
1 Year	18.02%	18.02%
2 Year	96.70%	40.25%
3 Year	100.44%	26.03%
5 Year	102.53%	15.15%
Since Inception	86.80%	10.57%

SIP Returns

The has given good returns on long-term SIP. In 2 Year SIP, the fund offered 18.46 annualized returns, and on 3-year SIP, 25.62% annualized returns.

SIP Period	Absolute Returns	Annualised Returns
1 Year	0.38%	0.71%
2 Year	20.30%	18.92%
3 Year	45.10%	25.75%
5 Year	69.27%	21.19%

Source - Money Control

Fund's Portfolio

The fund is invested in Indian equities to the tune of 97.38 percent, with 43.69 percent in large-cap stocks, 20.82 percent in mid-cap stocks, and 18.15 percent in small-cap stocks. The majority of the money in the fund is invested in the healthcare and insurance industries. In comparison to other funds in the category, it has less exposure to the healthcare and insurance industries. 

Sun Pharmaceutical Inds. Ltd., Cipla Ltd., Dr. Reddy's Laboratories Ltd., Apollo Hospitals Enterprise Ltd., and Divi's Laboratories Ltd. are the fund's top five holdings.

Disclaimer

Mutual fund investments are subject to market risk. Read all scheme-related documents, and Terms and Conditions carefully before investing. The above-mentioned information is purely informational and doesn't guarantee any return. The Greynium Information Technologies and the Author are not liable for any losses caused as a result of a decision based on the article.